Subscribe for the Newsletter

Mobile Navigation

Eliminating Immunosuppression in Regenerative Medicine

iTolerance

iTolerance

Apr 29, 2022PAO-04-22-R250-74

In an interview as part of Pharma's Almanac's the Road to 50 States campaign, Anthony Japour President and CEO at iTolerance, Inc., talks to Nigel Walker about the meaning and impact of ITolerance’s tagline “Pioneering Regenerative Medicine Without Immunosuppression.”

Nice Insight is the market research division of That's Nice LLC, the leading marketing agency serving life sciences.
Subscribe for the newsletter
© 2026 PHARMA'S ALMANAC. All rights reserved.